antibodydepend
enhanc
ade
felin
infecti
periton
viru
fipv
infect
recogn
experiment
infect
cat
cellular
immun
consid
play
import
role
prevent
onset
felin
infecti
periton
fip
present
studi
synthes
eightyon
kind
peptid
deriv
spike
domain
type
fipv
strain
domain
type
ii
fipv
strain
nucleocapcid
n
protein
fipv
strain
detect
helper
th
epitop
peripher
blood
mononuclear
cell
pbmc
obtain
fipvinfect
cat
cultur
peptid
immun
respons
measur
use
felin
interferon
fifn
product
index
detect
linear
immunodomin
antibodybind
epitop
investig
reactiv
plasma
collect
fipvinfect
cat
peptid
elisa
four
peptid
contain
epitop
identifi
heptad
repeat
hr
interhel
ih
region
domain
type
fipv
respect
locat
ntermin
side
region
domain
type
ii
fipv
peptid
contain
epitop
identifi
ih
region
respect
mainli
locat
ctermin
side
region
domain
type
fipv
peptid
contain
linear
immunodomin
antibodybind
epitop
identifi
ih
region
respect
domain
type
ii
fipv
peptid
contain
linear
immunodomin
antibodybind
epitop
identifi
region
epitop
domain
type
ii
fipv
locat
differ
region
linear
immunodomin
antibodybind
epitop
mostli
locat
region
eight
peptid
contain
epitop
identifi
n
protein
peptid
deriv
residu
show
strong
induct
product
pbmc
isol
type
fipvand
type
ii
fipvinfect
nonfip
cat
n
protein
peptid
contain
linear
immunodomin
antibodybind
epitop
identifi
peptid
deriv
residu
show
strong
reactiv
plasma
type
fipvand
type
ii
fipvinfect
cat
linear
immunodomin
antibodybind
epitop
locat
differ
posit
domain
n
protein
result
may
provid
import
inform
develop
peptidebas
vaccin
fipv
infect
felin
coronaviru
fcov
coronaviru
belong
group
famili
coronavirida
fcov
classifi
type
ii
abbrevi
fcov
felin
coronaviru
fip
felin
infecti
periton
fipv
felin
infecti
periton
viru
fecv
felin
enter
coronaviru
hr
heptad
repeat
ih
interhel
ade
antibodydepend
enhanc
pbmc
peripher
blood
mononuclear
cell
correspond
author
accord
amino
acid
sequenc
spike
protein
type
consist
two
virus
felin
infecti
periton
fip
caus
fip
viru
fipv
nonfipcaus
felin
enter
coronaviru
fecv
fipv
fecv
type
distinguish
antigen
gene
level
differ
pathogen
cat
fip
fatal
diseas
mainli
caus
immun
complex
vascul
accompani
necrosi
pyogen
granulomat
inflamm
prevent
fip
variou
vaccin
virulenceattenu
live
inactiv
fipv
vaccin
investig
none
shown
suffici
efficaci
vaccin
rather
enhanc
develop
fip
intraperiton
inocul
fipv
induc
sever
clinic
sign
antifcov
antibodyposit
kitten
kitten
receiv
passiv
immun
serum
purifi
igg
antibodyposit
cat
compar
antibodyneg
kitten
result
experiment
studi
suggest
antibodydepend
enhanc
ade
fipv
infect
seriou
obstacl
prevent
fip
vaccin
potent
cellular
immun
induc
fipvinfect
nonfip
cat
cellular
immun
consid
play
import
role
prevent
fip
onset
thu
induct
cellular
immun
respons
essenti
vaccin
fipv
infect
fipv
consist
three
major
protein
nucleocapsid
n
protein
membran
protein
spike
protein
classifi
class
viru
fusion
protein
protein
exist
radial
protrud
trimer
viral
envelop
structur
function
divid
two
domain
name
domain
repres
ntermin
globular
head
ctermin
membranebound
stalk
respect
ctermin
domain
sequenti
contain
precoil
pc
region
put
fusion
peptid
fp
hydrophob
heptad
repeat
hr
interhel
ih
domain
cluster
aromat
amino
acid
domain
ntermin
respons
drive
viral
target
cell
membran
fusion
ntermin
domain
contain
receptorbind
epitop
neutral
antibodybind
epitop
ade
epitop
domain
n
protein
homolog
type
fipv
strain
type
ii
fipv
strain
respect
recent
report
helper
th
cytotox
tc
epitop
present
protein
n
protein
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
belong
coronavirida
fipv
also
report
immunodomin
antibodybind
epitop
present
protein
n
protein
sarscov
use
mous
experiment
model
previous
identifi
least
immun
responseinduc
epitop
immun
responseinduc
epitop
domain
fipv
strain
howev
epitop
locat
fipv
n
protein
induc
immun
respons
felin
immunocyt
identifi
import
develop
effect
peptidebas
vaccin
fipv
infect
includ
epitop
ade
epitop
present
studi
identifi
immunodomin
antibodybind
epitop
domain
n
protein
fipv
determin
linear
immunodomin
antibodybind
epitop
twentynin
thirti
twentytwo
kind
peptid
deriv
domain
type
fipv
strain
tabl
domain
type
ii
fipv
strain
tabl
n
protein
type
fipv
strain
tabl
respect
synthes
sigmaaldrich
fourteen
eleven
peptid
deriv
region
domain
fipv
strain
respect
thirteen
ten
peptid
deriv
region
domain
fipv
strain
respect
fortyeight
peptid
twentytwo
peptid
deriv
n
protein
synthes
fragment
overlap
four
seven
peptid
deriv
hydrophob
area
ih
domain
fipv
fipv
respect
peptid
purifi
puriti
higher
suppli
lyophil
powder
peptid
dissolv
dimethyl
sulfoxid
mgml
aliquot
store
c
type
fipv
strain
isol
laboratori
type
ii
fipv
strain
suppli
dr
mc
horzinek
state
univers
utrecht
netherland
fip
develop
cat
oronas
inocul
fipv
strain
develop
intraperiton
inocul
cat
cat
passiv
immun
antifcov
antibodi
intraperiton
inocul
fipv
strain
develop
fip
unpublish
data
oral
inocul
fipv
strain
induc
fip
antifcov
antibodyneg
cat
studi
use
twenti
cat
year
old
five
antifcov
antibodyneg
specif
pathogenfre
spf
cat
five
cat
inocul
oronas
type
fipv
strain
tcid
head
five
inocul
oronas
type
ii
fipv
strain
tcid
head
experiment
cat
develop
clinic
sign
fip
fipvinfect
nonfip
cat
five
cat
inocul
oronas
fipv
strain
develop
clinic
sign
typic
fip
fluctuat
fever
inappet
weight
loss
abdominalthorac
effus
cat
maintain
temperaturecontrol
isol
facil
experi
perform
accord
guidelin
anim
experi
kitasato
univers
twenti
millilitr
heparin
peripher
venou
blood
collect
jugular
vein
cat
pbmc
prepar
densiti
gradient
centrifug
blood
sampl
briefli
volum
peripher
blood
dilut
equal
volum
pb
layer
ficollhypaqu
axisshield
poc
norway
centrifug
layer
contain
pbmc
fraction
obtain
suspend
rpmi
sigma
usa
contain
heatinactiv
spf
cat
serum
penicillin
uml
streptomycin
gml
elisa
plate
sumitomo
bakelit
co
ltd
japan
coat
overnight
c
peptid
lwell
dilut
carbon
buffer
ph
wash
pb
contain
plate
block
block
buffer
contain
block
ace
ds
pharma
biomed
co
ltd
japan
pb
c
min
well
plate
receiv
l
plasma
fipv
cat
fipv
cat
spf
cat
min
incub
c
plate
wash
peroxidas
pod
conjug
goat
anticat
igg
mp
biomed
llccappel
product
usa
dilut
optim
concentr
l
dilut
ad
well
plate
incub
c
min
plate
wash
well
receiv
l
substrat
solut
incub
c
min
dark
substrat
solut
prepar
dissolv
ophenylenediamin
dihydrochlorid
concentr
mgml
citric
acid
na
hpo
buffer
ph
ad
lml
h
reaction
stop
n
h
solut
optic
densiti
od
nm
determin
antifelin
interferon
fifn
monoclon
antibodi
mab
use
detect
mab
prepar
laboratori
use
detect
prepar
mab
balbc
mice
inocul
intraperiton
mixtur
e
coli
express
pertussi
adjuv
mice
sacrif
obtain
splenic
cell
fusion
cell
fusion
carri
employ
essenti
method
describ
milstein
detect
system
sandwich
elisa
elispot
assay
twocolor
flow
cytometri
establish
use
mab
recogn
differ
epitop
submit
differ
epitop
recogn
mab
identifi
competit
elisa
neutral
test
pbmc
cellsml
cultur
synthes
peptid
gml
heatinactiv
viru
fipv
strain
tcid
ml
fipv
strain
tcid
ml
posit
control
cultur
medium
alon
neg
control
c
day
heatinactiv
fipv
fipv
cultur
fluid
heat
c
min
use
elisa
plate
thermo
fisher
scientif
inc
usa
coat
l
unlabel
mab
gml
carbon
buffer
c
overnight
plate
block
block
buffer
wash
l
cultur
supernat
standard
sampl
recombin
r
system
inc
usa
ad
well
incub
c
h
anoth
wash
l
biotinyl
mab
gml
ad
well
plate
incub
c
h
optim
dilut
horseradish
peroxidas
hrp
conjug
streptavidin
millipor
usa
ad
plate
incub
c
min
subsequ
treatment
convent
elisa
describ
minimum
detect
concentr
defin
standard
deviat
dose
measur
zero
dose
background
level
supernat
interpol
standard
calibr
curv
elispot
assay
perform
use
commerci
protein
detector
hrp
elispot
kit
kpl
inc
usa
briefli
polyvinyliden
fluorid
pvdf
back
micropl
coat
gml
unlabel
mab
c
overnight
plate
block
c
h
plate
receiv
ml
pbmc
incub
synthes
peptid
gml
heatinactiv
fipv
strain
tcid
ml
posit
control
cultur
medium
alon
neg
control
c
h
pbmc
remov
plate
receiv
gml
biotinyl
mab
incub
c
h
plate
process
accord
manufactur
instruct
result
spot
count
stereomicroscop
zellnet
consult
inc
usa
bluecolor
spot
fuzzi
border
score
spotform
cell
sfc
small
lymphocyt
lymphoblast
popul
gate
basi
cell
size
granular
forward
side
scatter
sampl
event
record
percentag
cell
popul
calcul
result
express
mean
sem
student
ttest
employ
determin
signific
differ
stimul
unstimul
cultur
sandwich
elisa
elispot
assay
flow
cytometri
od
valu
fipvinfect
cat
spf
cat
elisa
pvalu
p
consid
signific
pbmc
obtain
five
fipv
nonfip
cat
three
spf
cat
cultur
peptid
deriv
domain
fipv
strain
fig
left
panel
fipv
nonfip
cat
concentr
supernat
pbmc
cultur
six
kind
peptid
heatinactiv
fipv
significantli
higher
pbmc
cultur
medium
alon
spf
cat
level
supernat
pbmc
cultur
significantli
higher
pbmc
cultur
medium
alon
reactiv
plasma
collect
five
fipv
nonfip
cat
three
spf
cat
peptid
exam
ine
elisa
fig
right
panel
od
valu
plasma
fipv
cat
ten
kind
peptid
signific
higher
spf
cat
pbmc
obtain
five
fipv
nonfip
cat
three
spf
cat
cultur
individu
peptid
deriv
domain
fipv
strain
fig
left
panel
fipv
nonfip
cat
level
supernat
pbmc
cultur
seven
kind
peptid
heatinactiv
fipv
significantli
higher
pbmc
cultur
medium
alon
spf
cat
concentr
supernat
pbmc
cultur
signific
higher
pbmc
cultur
medium
alon
reactiv
plasma
collect
five
fipv
nonfip
cat
three
spf
cat
peptid
examin
fig
right
panel
od
valu
plasma
fipv
cat
four
kind
peptid
signific
higher
spf
cat
pbmc
obtain
five
fipv
nonfip
cat
five
fipv
nonfip
cat
three
spf
cat
cultur
peptid
deriv
n
protein
fipv
strain
fig
left
panel
fipv
nonfip
cat
concentr
supernat
pbmc
cultur
six
kind
peptid
heatinactiv
fipv
significantli
higher
pbmc
cultur
cultur
medium
alon
fipv
nonfip
cat
level
supernat
pbmc
cultur
six
kind
peptid
heatinactiv
fipv
significantli
higher
pbmc
cultur
cultur
medium
alon
spf
cat
concentr
supernat
increas
even
pbmc
cultur
either
peptid
reactiv
plasma
collect
five
fipv
nonfip
cat
fipv
nonfip
cat
three
spf
cat
peptid
examin
fig
right
panel
od
valu
plasma
fipv
fipv
cat
three
four
kind
peptid
respect
signific
higher
spf
cat
peptid
deriv
n
protein
type
fipv
strain
induc
specif
signific
product
stimul
pbmc
isol
type
fipv
nonfip
cat
also
type
ii
fipv
nonfip
cat
thu
investig
product
induct
pbmc
fipv
nonfip
cat
fip
cat
spf
cat
pbmc
fipvinfect
nonfip
cat
also
stimul
induc
product
neg
control
peptid
pbmc
obtain
fipv
nonfip
cat
significantli
produc
follow
stimul
heatinactiv
fipv
fig
hand
pbmc
deriv
fip
cat
spf
cat
produc
heatinactiv
fipv
stimul
neg
control
peptid
induc
product
pbmc
fipv
nonfip
cat
fip
cat
spf
cat
pbmc
obtain
fipv
nonfip
cat
significantli
increas
cell
follow
stimul
heatinactiv
fipv
fig
howev
pbmc
deriv
fip
cat
spf
cat
increas
cell
heatinactiv
fipv
stimul
increas
cell
respons
stimul
neg
control
peptid
note
pbmc
fipv
nonfip
cat
fip
cat
spf
cat
result
twocolor
flow
cytometri
pbmc
obtain
fipv
nonfip
cat
cell
significantli
increas
heatinactiv
fipv
stimul
fig
b
stimul
pbmc
deriv
fipv
nonfip
cat
significantli
increas
cell
fig
pbmc
nonfip
cat
stimul
number
cell
increas
although
increas
signific
hand
cell
among
pbmc
deriv
fip
cat
spf
cat
increas
heatinactiv
fipv
stimul
cell
pbmc
fipv
nonfip
cat
fip
cat
spf
cat
increas
respons
stimul
neg
control
peptid
recent
studi
mice
human
demonstr
memori
cell
rapidli
produc
follow
stimul
cognat
antigen
similar
observ
also
made
sarscov
infect
sarscovspecif
memori
cell
sarsrecov
donor
rapidli
produc
follow
shortterm
stimul
inactiv
sarscov
protein
deriv
sarscov
hand
pbmc
deriv
critic
sar
die
sar
appar
could
produc
sarscov
antigen
stimul
suggest
memori
cell
ie
cellular
immun
respons
particip
viral
clearanc
recov
sar
patient
similarli
found
pbmc
obtain
fipvinfect
nonfip
cat
specif
significantli
produc
heatinactiv
fipv
stimul
fip
cat
submit
result
substanti
previou
find
cellular
immun
play
import
role
defens
fipv
infect
thu
induct
cellular
immun
respons
essenti
develop
vaccin
fipv
infect
detect
epitop
includ
ade
epitop
synthes
eightyon
kind
peptid
deriv
domain
n
protein
fipv
epitopecontain
peptid
identifi
ih
region
domain
fipv
strain
epitop
locat
ntermin
side
ih
region
similarli
epitopecontain
peptid
identifi
ih
region
domain
fipv
strain
mani
epitop
locat
ctermin
side
region
suggest
posit
epitop
domain
differ
type
fipv
type
ii
fipv
strain
domain
fipv
linear
immunodomin
antibodybind
epitopecontain
peptid
identifi
ih
region
similarli
linear
immunodomin
antibodybind
epitopecontain
peptid
identifi
region
domain
fipv
suggest
unlik
epitop
mani
linear
immunodomin
antibodybind
epitop
domain
present
region
type
fipv
type
ii
fipv
linear
immunodomin
antibodybind
epitop
domain
present
differ
posit
differ
posit
immunodomin
antibodybind
epitop
domain
sarscov
also
report
analysi
n
protein
epitopecontain
peptid
specif
significantli
induc
product
pbmc
type
fipv
type
ii
fipv
nonfip
cat
identifi
two
linear
immunodomin
antibodybind
epitopecontain
peptid
specif
significantli
induc
antibodi
fig
detect
cell
specif
induc
peptid
pbmc
deriv
five
fipv
nonfip
cat
five
fip
cat
five
spf
cat
cell
cultur
dot
bar
obliqu
bar
stripe
bar
peptid
control
heatinactiv
fipv
posit
control
solid
bar
cultur
medium
neg
control
open
bar
detect
cell
small
lymphocyt
lymphoblast
popul
use
twocolor
flow
cytometri
yaxi
denot
fold
increas
peptid
specif
cell
percentag
cell
pbmc
cultur
peptid
heatinactiv
fipv
percentag
cell
pbmc
cultur
medium
alon
b
repres
mean
sem
fold
increas
peptid
specif
cell
respect
indic
signific
differ
compar
cultur
medium
alon
p
product
type
fipv
type
ii
fipv
nonfip
cat
also
identifi
similarli
domain
linear
immunodomin
antibodybind
epitop
locat
differ
posit
n
protein
differ
locat
immunodomin
antibodybind
epitop
n
protein
sarscov
also
report
domain
homolog
type
fipv
type
ii
fipv
strain
thu
use
pbmc
plasma
type
fipvinfect
cat
detect
linear
immunodomin
antibodybind
epitop
type
fipv
domain
similarli
pbmc
plasma
type
ii
fipvinfect
cat
use
identifi
linear
immunodomin
antibodybind
epitop
type
ii
fipv
domain
describ
epitop
locat
domain
differ
fipv
fipv
hand
n
protein
homolog
type
fipv
type
ii
fipv
strain
specif
significantli
induc
product
pbmc
isol
type
fipv
also
type
ii
fipv
nonfip
cat
sinc
acid
overlap
sequenc
investig
specif
product
induct
pbmc
fipv
cat
show
potent
product
induct
pbmc
type
ii
fipv
nonfip
cat
pbmc
fip
spf
cat
found
percentag
cell
markedli
increas
thu
stimul
pbmc
obtain
fipv
nonfip
cat
increas
product
particularli
fipvspecif
memori
cell
suggest
includ
epitop
hand
pbmc
obtain
fip
cat
percentag
cell
increas
stimul
similarli
report
cytotox
lymphocyt
ctl
markedli
induc
sarscov
antigen
stimul
sarsrecov
donor
critic
sar
die
sar
small
synthet
peptid
correspond
ctl
epitop
shown
highli
effect
induct
strong
protect
ctlmediat
immun
infecti
viru
murin
model
peptid
present
ctermin
domain
protein
sarscov
also
known
induc
strong
ctl
activ
regard
candid
vaccin
develop
also
report
n
protein
infecti
bronchiti
viru
ibv
mous
hepat
viru
mhv
belong
coronavirida
major
target
ctl
memori
respons
thu
deriv
n
protein
fipv
strain
may
use
elicit
cellular
immun
respons
potenti
candid
peptidebas
vaccin
develop
prevent
type
type
ii
fipv
infect
conclus
identifi
linear
immunodomin
antibodybind
epitop
domain
n
protein
fipv
linear
immunodomin
antibodybind
epitop
locat
differ
posit
domain
n
protein
peptid
deriv
n
protein
fipv
strain
specif
significantli
induc
cell
pbmc
fipvinfect
nonfip
cat
result
may
provid
import
inform
develop
peptidebas
vaccin
fipv
infect
